Moderna, Inc.
Biological Products, (No Diagnostic Substances) · Cambridge, MA, United States
- PrincipalsJames M MockChief Financial OfficerShannon Thyme KlingerChief Legal OfficerStephane BancelChief Executive Officerand 3 more
- CompanyModerna, Inc.Cambridge, MA, United States
- Phone line+1 (617) 714-6500General business
Moderna, Inc. is an SEC-registered Nasdaq-listed company (ticker MRNA) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 6
Finance
James M MockChief Financial Officer
Legal
Shannon Thyme KlingerChief Legal Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗James M Mock — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Shannon Thyme Klinger — Chief Legal Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Stephen Hoge — President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Stephane Bancel — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Crispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capability